SC 13D/A:超过5%持股股东披露文件(修正)-Parag Saxena(18.5%),Vedanta Partners, LLC(15.9%)等
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | SC 13D/A:超过5%持股股东披露文件(修正)-Laxminarayan Bhat(10.2%)
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | SC 13G/A:超过5%持股股东披露文件(修正)-TANG CAPITAL PARTNERS, LP(9.99%),TANG CAPITAL MANAGEMENT, LLC(9.99%)等
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | SC 13G:超过5%持股股东披露文件-Armistice Capital, LLC(6.32%),Steven Boyd(6.32%)
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | SC 13D/A:超过5%持股股东披露文件(修正)-Parag Saxena(19.9%),Vedanta Partners, LLC(19.4%)等
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 4:持股变动声明-董事 SAXENA PARAG
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 4:持股变动声明-董事 Funtleyder Leslie D.
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 4:持股变动声明-董事 Margolin Richard A
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 4:持股变动声明-董事 Patel Purav
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 4:持股变动声明-董事 SAXENA PARAG
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | SC 13D/A:超过5%持股股东披露文件(修正)-Laxminarayan Bhat(13.5%)
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 4:持股变动声明-高管 Bhat Laxminarayan
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 4:持股变动声明-首席财务官 Narayan Prabhu
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | SC 13G/A:超过5%持股股东披露文件(修正)-TANG CAPITAL PARTNERS, LP(9.99%),TANG CAPITAL MANAGEMENT, LLC(9.99%)等
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 4:持股变动声明
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 4:持股变动声明
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 4:持股变动声明
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 4:持股变动声明
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 4:持股变动声明
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 4:持股变动声明
暂无数据